We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Caretech Holdings Plc | LSE:CTH | London | Ordinary Share | GB00B0KWHQ09 | ORD 0.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 750.00 | 749.00 | 750.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCTH
RNS Number : 4002I
CareTech Holdings PLC
19 June 2017
For immediate release 19 June 2017
CareTech Holdings PLC
("CareTech" or the "Company")
Interim Results for the six months ended 31 March 2017
CareTech Holdings PLC (AIM: CTH), a pioneering provider of specialist social care services in the UK, is pleased to announce its interim results for the six months ended 31 March 2017.
Financial Highlights
-- Revenue increased by 11.3% to GBP78.8m (H12016: GBP70.8m) -- Underlying EBITDA(i) increased by 8.3% to GBP18.3m (H12016: GBP16.9m) -- Underlying profit before tax(ii) increased by 13.9% to GBP13.1m (H12016: GBP11.5m) -- Underlying diluted earnings per share(ii) increased by 11% to 16.37p (H12016: 14.75p)
-- Operating profit decreased by 28.5% to GBP10.7m (H12016: GBP15.0m) and profit before tax decreased by 37.5% to GBP7.0m (H12016: GBP11.2m) principally due to GBP5.6m profit on sale of fixed assets in 2016
-- Strong operating cash inflow before non-underlying items of GBP15.8m (H12016: GBP15.6m) with net debt of GBP122.5m at 31 March 2017 (31 March 2016: GBP156.4m) (iii)
-- Interim dividend increased by 10% to 3.30p (2016: 3.00p) per share -- Net assets have grown by 38.5% to GBP195.2m (H12016: GBP140.9m) -- Cash inflows from operating activities were GBP11.4m (H12016: GBP13.8m) -- Placing of 11,000,000 new shares raising GBP37m (net of expenses) -- Improved banking facilities with the deferral of two loan repayments
Strategic Highlights
-- After the half year end there was an acquisition investment of GBP20.7m of placing proceeds in Beacon Reach and Selborne Care (see separate release announced today)
-- Recent acquisitions Spark of Genius, Oakleaf Care (Hartwell) and ROC North West have continued to grow
-- Further strengthening of the management team and additional I.T. infrastructure -- Overall net capacity increased since the year end by 40 places -- Improved quality ratings particularly with CQC
-- Disability confident level 3 accreditation obtained and CareTech Charitable Foundation established
Commenting on the results, Farouq Sheikh, Executive Chairman of CareTech, said:
"We are pleased to report an impressive performance for the first half of 2017 which delivered year on year growth in revenue, underlying EBITDA, underlying profit before tax and underlying EPS.
"Having raised GBP37m of net proceeds from the share placing in March 2017, the Group has completed on two acquisitions with a total spend of GBP20.7m since the half year ended. A number of potential acquisition opportunities are under active consideration and in addition we have a strong organic pipeline of additional beds in reconfigured services and in new services.
"The Directors believe that this will lead to a sustained growth in capacity and revenues which will generate additional EBITDA and cash so that the Group can achieve its target of double digit growth annually in underlying diluted earnings per share.
"It is pleasing to recognise the hard work that has gone into the disability confident level 3 accreditation. Also the creation of the CareTech Charitable Foundation is an exciting initiative to make a difference to support service users and our staff and their families plus contribute to disability related causes.
"The continued provision of first-class social care which represents good value and is focused on successful service user outcomes will remain the main market driver for CareTech's continuing growth."
(i) Underlying EBITDA is operating profit stated before depreciation, share -based payments charge and non-underlying items explained in note 3.
(ii) Underlying profit before tax and underlying diluted earnings per share are stated before non-underlying items (explained in note 3).
(iii) Net debt is defined by the Group's banking facilities and comprises cash and cash equivalents net of loans and borrowings.
(iv) EBITDA is operating profit stated before depreciation, share-based payments charge and amortisation of intangible assets.
For further information, please contact:
CareTech Holdings PLC Farouq Sheikh, Executive Chairman Michael Hill, Group Finance Director 01707 601 800 Buchanan (PR Adviser) Mark Court Sophie Cowles Stephanie Watson 020 7466 5000 Panmure Gordon (Nomad and Joint Broker) Freddy Crossley Peter Steel Charles Leigh-Pemberton 020 7886 2500 WH Ireland (Joint Broker) Adrian Hadden James Bavister 020 7220 1666
This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014
About CareTech
CareTech Holdings plc is a leading provider of specialist social care services, supporting adults and children with a wide range of complex needs in more than 260 specialist services around the UK.
Committed to the highest standards of care and care governance, CareTech provides its innovative care pathways through five divisions covering adult learning disabilities, specialist services, young people residential services, foster care and learning services which come under the two outcome-based sectors of Adult Services and Young People Services.
CareTech, which was founded in 1993, began trading on the AIM market of the London Stock Exchange in October 2005 under the ticker symbol CTH. Its property portfolio comprises more than 200 properties.
For further information please visit: www.caretech-uk.com.
Chairman's Statement
The solid platform has continued to deliver strong organic growth as well as multiple acquisition opportunities planned
I am pleased to report another solid performance in the six months ended 31 March 2017. CareTech has delivered an impressive performance increasing revenue, underlying EBITDA, and underlying profit before tax compared with the comparable period in 2016. The strong performance further demonstrates the benefits of the Board's strategy over recent years, in which it has actively sought to:
-- Create complementary care pathways focused on outcomes for service users -- Reconfigure the existing property portfolio to meet market demand -- Invest in people and I.T. systems
-- Strengthen the balance sheet through a combination of share placements and improved banking facilities
-- Accelerate organic growth complemented by bolt-on acquisitions
The growth going forward is underpinned by the strong foundation that we have built over the past few years and the Group continues to develop and grow its five operating divisions, which come under the two outcome-based sectors of Adult services and Young People services. We continue to extend both our geographic coverage and our outcome based care pathway range of services organically and through the purchase and sale of properties to meet the needs of our marketplace, specifically the requirement for greater acuity service provision. This indicates that CareTech is in a very strong position to address the demands of our evolving marketplace and the Board remains confident of the Group's performance for the remainder of the year.
Following the recent share placement and improved banking facilities plus further strengthening of the management team, the Group is ideally placed to make further bolt-on acquisitions to our existing care pathways in a market that remains very fragmented. We are also currently making good progress on a number of organic projects adding beds in reconfigured services and in new services where we have acquired properties in the North West, West of England and Scotland.
Our current initiatives and acquisition strategy give the Group the ability to achieve double digit growth annually in underlying diluted earnings per share going forwards.
Our performance during the first half of the current year has been underpinned by the strategic initiatives undertaken over recent years which have delivered a stronger performance compared with the same period last year on all of the key financial metrics.
CareTech's care pathways continue to be a key foundation to delivering positive outcomes for our service users. By helping them to live more independently, we are working in partnership with local authorities by providing them with greater value for money.
Results
Group revenue in the half year has grown by 11.3% to GBP78.8m (H12016: GBP70.8m) has delivered an underlying EBITDA (i) of GBP18.3m (H12016: GBP16.9m), representing growth of 8.3%. Without the effect of reconfigurations and acquisitions Group revenue and EBITDA would have grown on a like for like basis by 4.2 % and 2.6 % respectively; this constitutes an investment for the future and allows the Group to meet Commissioner demands whilst expanding our care pathways and geography.
The underlying EBITDA(i) margin was 23.2% (H12016: 23.8%) having made further investment in the management team and reflecting the change of mix in margins for some of the acquired businesses. Underlying margins continue to improve through reconfigurations and operational efficiencies and have grown from 20.9% in HI2013 and 22.6% in H12014 to 23.8% in H12015.
Underlying profit before tax(ii) increased by 13.9% to GBP13.1m (H12016: GBP11.5m) and underlying diluted earnings per share(ii) was 16.37p (2016: 14.75p) This increase of 11% is due to the growth in underlying earnings arising from the improved EBITDA and lower financial expenses partially offset by an increase in the number of shares issued in March 2017 as a result of the placing.
Operating profit, profit before tax and EPS are lower than the first half of 2016 principally due to the profit on sale of fixed assets as a result of the ground rent transaction.
During this period, we also maintained our strategic focus towards taking the Group's operational platform forward to the next stage of development in what is a growing market. As a consequence, we have further invested in our property estate, our IT systems and operating structure in order to provide the appropriate quality and resource to drive medium term growth organically, investing GBP9.2m in the period (H12016: GBP6.1m). Additionally, following our analysis in the past two years of demand trends, new services and new properties are being developed including further children's services in Scotland, and further homes in North West and West of England. Homes are being reconfigured to meet new demand and service requirements of Care Commissioners in the West Midlands and North West England and these are planned to be completed in the coming months.
Care commissioners continue to demand flexible high quality care solutions and favour operators able to deliver across the care pathway. Pleasingly, some of the 2016 reconfigured services that have opened are already experiencing strong levels of demand from local authorities for referrals, validating our strategy of reconfiguration focusing upon greater acuity service provision.
A key feature of this business is its strong cash generation. Operating cash inflow before non-underlying items of GBP15.8m represents a 86% cash conversion of underlying EBITDA(i), which demonstrates the continued strong quality of our earnings. As a result of this and the focus on organic growth as well as the net share placement monies, net debt as defined by the Group's bank facilities was GBP122.5m at 31 March 2017 GBP33.9m lower than the year end position at 30 September 2016 of GBP156.4m.
Net assets have increased by GBP43.6m in the half year to 31 March 2017 which is an increase of 30.9% compared with March 2016 due mainly to the share placement.
In the trading update issued on 27 April 2017, CareTech announced that, annual fee rate negotiations with local authorities remain at an early stage and this year are taking place against the backdrop of an increase in the Living Wage to GBP7.50 per hour from 1 April 2017. The Board anticipates that a more positive outcome will be achieved than in recent years and that the costs associated with the Living Wage will be fully absorbed by fee increases.
Dividend
Our policy continues to be to increase the dividend broadly in line with the movement in underlying diluted earnings per share. Given the consistent earnings growth and cash generation the Board is therefore declaring an interim dividend of 3.30p (H12016: 3.00p) per share, to be paid on 24 November 2017 to shareholders on the Register of Members on 26 October 2017 with an associated record date of 27 October 2017.
Service user capacity and occupancy
During the half year there was a total net increase of 40 residential and fostering places. There were 13 additional beds in reconfigured services and in new services there were 20 new beds in Adults and 20 new beds in Children's. These generate a higher contribution than the beds pre-configuration and are part of our ongoing strategy to enhance margins. There were 13 new beds withdrawn for reconfiguration in the half year. There was no change of capacity in fostering. The Group's net capacity at the half year was 2,359 places (2,319 places as at 30 September 2016). Once the services have been reconfigured, we expect them to contribute a higher profit margin than previously.
Compared with 30 September 2016, occupancy levels in the mature estate are unchanged at 93% and the blended occupancy is also unchanged at approximately 86%.
Share Placement
The Board decided to make further acquisitions after a number of bolt-on targets were identified which could enhance the geographic spread of services and improve the care pathways.
On 23 March 2017, CareTech announced a share placing which raised approximately GBP37 million (net of expenses). A number of organic growth projects and potential bolt-on acquisitions have been identified and the intention is that the placing proceeds be deployed within approximately twelve months.
We continue to make good progress with a number of these opportunities. We undertake a thorough review process of new potential targets by a small senior team and have a strong pre- and post-implementation focus. The success of recent acquisitions and their integration into our core business is the template for future projects.
On 28 March 2017, 344,305 new ordinary shares were issued as part of the arrangements for full and final settlement of the earn-out agreed with the vendors of ROC North West Limited ("ROC"), acquired by the Company in December 2015. The new ordinary shares were issued at a deemed price of 365 pence per share. The new shares were listed on AIM on 3 April 2017.
The four banks in the Group's banking syndicate agreed on 28 March 2017 to defer repayment of the loan instalments due on 1 April 2017 and on 1 October 2017 until January 2019. The Company plans to make these additional funds of GBP11.55m available for the purchase of more properties and bolt-on acquisitions.
Acquisitions
Since the half year ended the first GBP3.8m has been committed to the acquisition and development of Beacon Reach near Preston, a children's education and residential facility previously registered for 34 residential places set on 18 acres of pastureland.
The Group is also pleased to announce that it has agreed to acquire the entire issued share capital of Selborne Care Limited for a total consideration of GBP16.9m in cash (see separate release announced today).
Selborne is a high quality provider of specialist residential care, supported living and day care services for adults with learning disabilities and challenging behaviours. Selborne is based in Droitwich and operates across the Midlands and the South West.
Residential care services are provided through 8 care services with a combined capacity of 57 beds.
Supported living services are provided to 30 service users. Innovative outreach and day services are also offered.
These two acquisitions utilise GBP20.7m of the funds raised from the share placement.
Operating review
The Group continues to benefit from the organisational improvements put in place over the past few years. In the half year, we have continued to strengthen the management structure and improve the efficiency of our processes following further investment in new systems which will continue through the second half of the year. Our recent appointments have put us in a strong position to benefit from a number of commissioning opportunities by working in partnership with the NHS and Local Authorities especially in light of Joint Commissioning currently being developed.
The Time and Attendance system, which had been implemented across residential services before the half year, provides margin improvements at homes level and it further progresses our back office centralisation which continues in the second half year with further new IT developments.
A summary outline of our divisions and sectors:
For the time being we continue to report the five operating divisions with their individual statistics and we report Adult Services which is the total of Adult Learning Disabilities and Specialist Services, and Young People Services which is the total of Young People Residential, Fostering and Learning Services.
Adult Services
The Adult Services capacity is 1,799 with Revenue growing by 14.0% to GBP48.0m (H12016: GBP42.1m) and EBITDA by 10.5% to GBP13.7m (H12016: GBP12.4m). The sector's margin has come back a little to 28.6% (HI2016 29.5%) as a result of the investment in further reconfigurations and service mix.
Adult Learning Disabilities - with a client capacity at 31 March 2017 of 1,604 places and first half revenue of GBP40.3m, this division represents 51% of the Group's activities. We continue to offer a flexible, person-centred approach with support being offered on an individual planned basis. Demand remains high for the support of people with learning disabilities and we recognise an increasing complexity of need for referrals to our specialist services. We have identified a small number of additional learning disability residential services to reconfigure into services that provide a greater level of acuity and these are being developed with further services opening in Supported Living in the North West and South East. A contract has been won to start in August 2017 in Supported Living in Wigan which will be for 36 beds. The focus on quality continues with the Care Quality Commission new ratings for the Group's services being rated better than the national averages.
Specialist Services - our care pathway for specialist services includes a small community based "open" hospital, residential care homes, independent supported living and community outreach. We also include all adult specialised services in this portfolio including Oakleaf with its care and rehabilitation of men with acquired brain injury. At 31 March 2017 the division had a capacity of 195 places and generated revenue of GBP7.7m in the first half of our financial year up 126.7% on March 2016 principally due to Oakleaf being included for the full half year rather than just March 2016 when it was acquired.
Young People Services
The Young People Services capacity is 560 with revenues growing by 7.0% to GBP30.8m (H12016: GBP28.7m) and EBITDA by 6.6% to GBP8.0m (H12016: GBP7.5m). The underlying focus of providing a complete care pathway for Young People is now coming through with much more strength and the sector also reflects the acquisition of ROC in December 2015 for the full half year with both ROC and Spark of Genius opening new services in the half year.
Young People Residential Services - provides care, support and education to young people with complex behavioural problems, physical impairments, learning disabilities and emotional behavioural disorders ('EBD'). This division generated revenue of GBP20.8m and had a capacity at 31 March 2017 of 259 places. We operate services that cater for local needs but also manage certain highly specialised services that have a national catchment. Since 2012 the Group gained a foothold in Scotland and this was further extended through the acquisition of Spark of Genius and with the opening of additional services in Fife and Paisley. The division focuses increasingly on those children with the most complex needs and those who require our sophisticated clinical input.
Foster Care - with a capacity of 301 children we have established ourselves as one of the largest independent fostering agencies in England and Wales. The division had turnover of GBP4.3m in the six months to 31 March 2017. We have observed a significantly increased demand for foster care for children who might otherwise have entered the residential care system. Foster care represents much better value for commissioners but the complexity of children being referred will often make the matching process quite complex, favouring larger agencies like CareTech with a greater range of well supported foster carers.
Learning Services - Revenue to 31 March 2017 was GBP5.7m in the first half of the financial year and includes Dawn Hodge Associates (DHA) which has just had an Ofsted outcome of "outstanding" as an independent learning provider. The Group has expanded the new CareTech Aspire Programme in this half year; it will ensure that all of CareTech's care staff receive all mandatory and statutory training to the highest standard whilst also being offered the opportunity to complete a Level 2 or Level 3 apprenticeship which has been carefully tailored to suit individual roles.
The Aspire programme aims to empower every member of staff to deliver high quality, personalised care and ensure there is a development pathway available to all. From November 2014, all newly hired support workers have been offered an apprenticeship as part of their induction to CareTech. To date 178 CareTech care staff have completed their apprenticeship programme and 393 are still undergoing their apprenticeship. There are also 58 CareTech managers on the Level 5 Health and Social Care Diploma which is offered, provided and supported by EQL.
This programme is one of a number of initiatives being taken on staff development and retention. There is also good progress on Pre-Employment Training Courses for Young People which are being introduced into some of our Young People Residential Services.
As an employer, CareTech is a registered apprenticeship training provider in its own right and the Board is convinced of the benefits that our apprenticeship programme has had for both our own staff and for the users of our services. The apprenticeship levy is an opportunity to continue to deliver excellence in the care sector and is a tangible example of the Group's commitment to training and retaining its workforce. The Group is also fully committed to Disability Confident and has achieved the employer scheme accreditation to level 3.
Strategy
The specialist social care market continues to benefit from strong demographic trends and higher acuity levels across the UK. Local Authorities are faced with increasing demands and financial pressures that have led to a greater focus on value for money. CareTech's experience has been that service commissioners recognise that the most complex people require continuing support which focuses on outcome based care pathways.
For those able to transition we provide clear outcome-based pathways from residential care, principally into various forms of supported housing or foster care for children, while residential options continue to be in demand for those with the greatest need. However, we anticipate further shifts toward more sophisticated supported living packages linked to new personalised payment methodologies.
Our diversification policy means that we are now offering the full spectrum of social care services with the exception of traditional elderly care. We believe that our strategic position is now very strong, backed by an effective organisational structure, first class quality control and developing clinical infrastructure. In the medium term we are focusing on organic growth that builds on our successful base position. However, we will undertake further strategic acquisitions that meet our key criteria by offering new expertise, geographical presence or consolidation opportunities.
People
There have been no changes to the Board, the Remuneration Committee, Care Governance and Safeguarding Committee or the Audit Committee in the half year.
As a foundation for growth the Senior Executive Team at CareTech has been further strengthened in the half year and we will continue to bring senior executives into the business to help build a strong foundation from which to drive growth and quality. The Adults Learning Disabilities Division is now managed by two managing directors having been split into two regions to enable geographic focus, and a new Children's managing director has been appointed. A further appointment will be a Specialist Services managing director to reflect the broadening of acuity services. The Learning Division and Compliance teams have also being strengthened.
The Group is repeating the Sharesave scheme for all staff offered in 2016 and it is hoped that there will again be strong demand. The Group has also created the CareTech Charitable Foundation which is a Registered Charity with objectives to help those in need of assistance with education and provide support to disadvantaged people.
Outlook and prospects
The continued provision of first-class social care which represents good value and is focused on successful client outcomes will remain the main market driver for CareTech's continuing growth.
The proven strategy of taking the Group from a single division to now supporting five complementary divisions has given the Group a resilient foundation from which to build.
With a strengthened management team and having undertaken the share placement and with improved banking facilities in place, the Group has a number of consolidation opportunities and property projects which are currently being progressed. The Board believes that this will lead to a growth in capacity and revenues which will generate additional EBITDA and cash to continue organic and infrastructure improvements so the Group can achieve its target of double digit growth annually in underlying diluted earnings per share.
CareTech will continue to work in partnership with local authorities to deliver innovative services focused on delivering positive outcomes for individuals.
Farouq Sheikh
Chairman
19 June 2017
(i) Underlying EBITDA is operating profit before depreciation, share-based payments charge
and non underlying items (explained in note 3);
(ii) Underlying profit before tax and underlying diluted earnings per share are stated before non underlying items (explained in note 3).
Condensed Consolidated Statement of Comprehensive Income
for the six months ended 31 March 2017
Hot Features
Premium
Six months ended Six months ended Year ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
------------------------------------- ----- ----------------------- ----------------------- ----------------------
Before non Before non Before non
underlying Total underlying Total underlying Total
items(i) unaudited items(i) unaudited items(i) audited
Note GBP000 GBP000 GBP000 GBP000 GBP000 GBP000
------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- ---------
Revenue 78,774 78,774 70,825 70,825 148,979 148,979
Cost of sales (50,447) (50,447) (45,661) (45,661) (94,682) (94,682)
------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- ---------
Gross profit 28,327 28,327 25,164 25,164 54,297 54,297
Administrative expenses (12,634) (17,585) (10,683) (10,134) (22,328) (23,838)
------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- ---------
Operating profit 15,693 10,742 14,481 15,030 31,969 30,459
EBITDA 3 18,331 18,331 16,850 16,850 37,056 41,289
Depreciation (2,608) (2,608) (2,344) (2,344) (5,026) (5,026)
Amortisation of intangible assets 3 - (3,363) - (2,865) - (5,743)
Share-based payments charge (30) (30) (25) (25) (61) (61)
------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- ---------
Profit on sale of fixed assets 3 - - - 5,623 - -
------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- ---------
Acquisition expenses 3 - - - (1,505) - - ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Share placing costs 3 - (348) - - - - ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Integration,reorganisation and redundancy costs 3 - (1,240) - (704) - - ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Operating profit 15,693 10,742 14,481 15,030 31,969 30,459 ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Financial expenses 4 (2,601) (3,729) (3,003) (3,834) (5,887) (7,924) ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Profit before tax 13,092 7,013 11,478 11,196 26,082 22,535 Taxation 5 (2,547) (1,638) (2,295) (2,477) (2,035) 336 ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Comprehensive income for the period attributable to equity shareholders of the parent 10,545 5,375 9,183 8,719 24,047 22,871 ------------------------------------- ----- ----------- ---------- ----------- ---------- ----------- --------- Earnings per share Basic 6 16.37p 8.35p 14.75p 14.00p 38.03p 36.17p Diluted 6 16.37p 8.35p 14.75p 14.00p 38.03p 36.17p (i) Non underlying items are explained in note 3.
Condensed Consolidated Statement of Changes in Equity at 31 March 2017
Six months ended Six months ended Year ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
------------------------------------------------------- ----------------- ----------------- ------------------
Balance at start of period 151,667 133,699 133,699
Total comprehensive income 5,375 8,719 22,871
Transactions with owners recorded directly in equity:
Issue of ordinary shares 57 214 258
Share premium on shares issued 38,749 - -
Reduction in shares held 1,272 (43) -
Equity settled share-based payments charge 30 25 61
Dividends (1,925) (1,739) (5,222)
------------------------------------------------------- ----------------- ----------------- ------------------
Balance at end of period 195,225 140,875 151,667
------------------------------------------------------- ----------------- ----------------- ------------------
Condensed Consolidated Balance Sheet at 31 March 2017
31 March 2017 31 March 30 September
2016 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
Non-current assets
Property, plant and equipment 272,719 263,432 267,667
Other intangible assets 43,087 44,628 43,982
Goodwill 43,021 43,049 43,021
358,827 351,109 354,670
---------------------------------------------------------------- -------------- ---------- -------------
Current assets
Inventories 815 562 815
Trade and other receivables 17,917 14,736 18,508
Cash and cash equivalents 9,843 4,103 4,308
---------------------------------------------------------------- -------------- ---------- -------------
28,575 19,401 23,631
---------------------------------------------------------------- -------------- ---------- -------------
Total assets 387,402 370,510 378,301
---------------------------------------------------------------- -------------- ---------- -------------
Current liabilities
Loans and borrowings 607 1,646 6,990
Trade and other payables 15,359 18,742 17,666
Deferred and contingent consideration payable 2,270 3,925 3,850
Ground rent liabilities arising under IAS17 50 59 50
Deferred income 1,933 2,114 2,119
Corporate Tax 9,096 9,512 9,250
Derivative financial instruments 724 425 1,083
30,039 36,423 41,008
---------------------------------------------------------------- -------------- ---------- -------------
Non-current liabilities
Loans and borrowings 131,724 158,590 153,742
Deferred and contingent consideration payable 1,872 2,025 2,025
Ground rent liabilities arising under IAS17 7,318 7,359 7,343
Deferred tax liabilities 20,472 24,386 21,552
Derivative financial instruments 752 852 964
162,138 193,212 185,626
---------------------------------------------------------------- -------------- ---------- -------------
Total liabilities 192,177 229,635 226,634
---------------------------------------------------------------- -------------- ---------- -------------
Net assets 195,225 140,875 151,667
---------------------------------------------------------------- -------------- ---------- -------------
Equity attributable to equity shareholders of the parent
Share capital 378 321 321
Share premium 120,499 81,664 81,750
Shares held by Employee Benefit Trust (4,800) (6,072) (6,072)
Merger reserve 9,023 9,022 9,023
Retained earnings 70,125 55,940 66,645
---------------------------------------------------------------- -------------- ---------- -------------
Total equity attributable to equity shareholders of the parent 195,225 140,875 151,667
---------------------------------------------------------------- -------------- ---------- -------------
Consolidated Cash Flow Statement for the six months ended 31 March 2017
Six months ended Six months ended Year ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
------------------------------------------------------- ----------------- ----------------- ------------------
Cash flows from operating activities
Profit before tax 7,013 11,196 22,535
Financial expenses 3,729 3,834 7,924
Depreciation 2,608 2,344 5,026
Amortisation of intangible assets 3,363 2,865 5,743
Share-based payments charge 30 25 61
Acquisition transaction costs - 1,505 660
Integration,reorganisation and redundancy costs 1,588 704 1,780
(Profit) on disposal of property, plant and equipment - (5,623) (5,623)
Operating cash flows before movement in working 18,331 16,850 38,106
capital and non- underlying items
(Increase) in inventory - - (253)
Decrease/(Increase) in trade and other receivables 142 (342) (3,498)
(Decrease) in trade and other payables (2,669) (863) (163)
Operating cash flows before non-underlying items 15,804 15,645 34,192
Integration and restructuring costs (1,449) (709) (1,780)
Payments under onerous contracts - - -
------------------------------------------------------- ----------------- ----------------- ------------------
Cash inflows from operating activities 14,355 14,936 32,412
Tax paid (2,873) (1,087) (1,458)
------------------------------------------------------- ----------------- ----------------- ------------------
Net cash from operating activities 11,482 13,849 30,954
------------------------------------------------------- ----------------- ----------------- ------------------
Cash flows from investing activities
Proceeds from sale of property, plant and equipment 125 29,726 29,854
Payments for business combinations net of cash acquired (427) (27,603) (27,603)
Acquisition of intangible items - (1,348) -
Acquisition of property, plant and equipment (7,048) (4,766) (10,765)
Acquisition of software (2,196) - (3,580)
Payment of acquisition costs - (2,303) (3,654)
Payment of ground rent transaction costs (197) - -
----------------------------------------------------------------- --------- --------- ---------
Net cash used in investing activities (9,743) (6,294) (15,748)
----------------------------------------------------------------- --------- --------- ---------
Cash flows from financing activities
Proceeds arising from the issue of share capital (net of costs) 37,548 75 75
Proceeds from new loan (net of costs) 9,627 27,950 -
Interest paid (2,556) (3,311) (5,544)
Cash outflow arising from derivative financial instruments (372) (321) (779)
Bank fees on refinancing - (443) 27,507
Repayment of borrowings (37,400) (28,377) (28,377)
Payment of finance lease liabilities (1,126) (988) (2,260)
Dividends paid (1,925) (1,739) (5,222)
----------------------------------------------------------------- --------- --------- ---------
Net cash used in financing activities 3,796 (7,154) (14,600)
----------------------------------------------------------------- --------- --------- ---------
Net change in cash and cash equivalents 5,535 401 606
----------------------------------------------------------------- --------- --------- ---------
Cash and cash equivalents at start of the period 4,308 3,702 3,702
----------------------------------------------------------------- --------- --------- ---------
Cash and cash equivalents at end of the period 9,843 4,103 4,308
----------------------------------------------------------------- --------- --------- ---------
Net debt as defined by the Group's banking facilities comprises:
31 March 2017 31 March 2016 30 September 2016
Unaudited unaudited audited
GBP000 GBP000 GBP000
------------------------------- -------------- -------------- ------------------
Cash and cash equivalents 9,843 4,103 4,308
Bank loans and borrowings (132,331) (160,488) (160,732)
Net debt at end of the period (122,488) (156,385) (156,424)
------------------------------- -------------- -------------- ------------------
Notes
1. Accounting policies
This interim report has been prepared on the basis of the accounting policies expected to be adopted for the year ending 30 September 2017. These are anticipated to be in accordance with the Group's accounting policies as set out in the latest annual financial statements for the year ended 30 September 2016.
All International Financial Reporting Standards ("IFRS"), International Accounting Standards ("IAS"') and interpretations currently endorsed by the International Accounting Standards Board ("IASB") and its committees as adopted by the EU and as required to be adopted by AIM-listed companies have been applied. AIM-listed companies are not required to comply with IAS 34 'Interim Financial Reporting' and accordingly the Company has taken advantage of this exemption.
The financial information in this interim report does not constitute statutory accounts for the six months ended 31 March 2017 and should be read in conjunction with the Group's annual financial statements for the year ended 30 September 2016. Financial information for the year ended 30 September 2016 has been derived from the consolidated audited accounts for that period which were unqualified.
The condensed consolidated interim financial statements for the six months to 31 March 2017 have not been audited or reviewed by auditors pursuant to the Auditing Practices Board guidance on Review of Interim Financial Information.
This unaudited interim report was approved by the Board on 6 June 2017.
2. Segmental information
IFRS 8 requires operating segments to be determined based on the Group's internal reporting to the Chief Operating Decision Maker ("CODM"). The CODM has been determined to be the Chief Executive Officer as he is primarily responsible for the allocation of resources to segments and the assessment of the performance of each of the segments.
The CODM uses underlying EBITDA as reviewed at monthly Executive Committee meetings as the key measure of the segments' results as it reflects the segments' underlying trading performance for the period under evaluation. Underlying EBITDA is a consistent measure within the Group.
Inter-segment turnover between the operating segments is not material.
Our two key segments are Adult Services (Adult) and Children Services (Children). Adult Services comprises the Adult Learning Disabilities (ALD) and Mental Health (MH) divisions and the Children Services comprises Young People Residential Services (YPR), Foster Care (FC) and Learning Services (Learning).
2. Segmental information continued
The segmental results for the six months ended 31 March 2017, six months ended 31 March 2016 and year ended 30 September 2016 and the reconciliation of the segment measures to the respective statutory items included in the consolidated financial information are as follows:
Six months ended 31 March 2017 Continuing Operations ALD SS Adults YPR FC Learning Children Total -------------------------------- ------- ------ ------- ------- ------ --------- --------- -------- Client Capacity 1,604 195 1,799 259 301 - 560 2,359 Revenue (GBP'000) 40,331 7,673 48,004 20,772 4,328 5,670 30,770 78,774 EBITDA (GBP'000) 11,577 2,142 13,719 6,247 1,102 686 8,035 21,754 -------------------------------- ------- ------ ------- ------- ------ --------- --------- -------- Six months ended 31 March 2016 Continuing Operations ALD MH Adults YPR FC Learning Children Total -------------------------------- ------- ------ ------- ------- ------ --------- --------- -------- Client Capacity 1,527 216 1,743 247 302 - 549 2,292 Revenue (GBP'000) 38,695 3,385 42,080 17,705 5,211 5,829 28,745 70,825 EBITDA (GBP'000) 11,315 1,090 12,405 5,617 1,328 536 7,481 19,886 -------------------------------- ------- ------ ------- ------- ------ --------- --------- -------- Year ended 30 September 2016 Continuing Operations ALD MH Adults YPR FC Learning Children Total -------------------------------- ------- ------ ------- ------- ------ --------- --------- -------- Client Capacity 1,577 206 1,783 235 301 - 536 2,319 Revenue (GBP'000) 84,351 5,748 90,099 38,980 8,714 11,186 58,880 148,979 EBITDA (GBP'000) 26,396 1,663 28,059 11,806 2,187 1,013 15,006 43,065 -------------------------------- ------- ------ ------- ------- ------ --------- --------- --------
Reconciliation of EBITDA to profit after tax:
Six months ended Six months ended Year ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
-------------------------------------------- ----------------- ----------------- ------------------
Underlying EBITDA before unallocated costs 21,754 19,886 43,065
Unallocated costs (3,423) (3,036) (6,009)
-------------------------------------------- ----------------- ----------------- ------------------
Underlying EBITDA 18,331 16,850 37,056
Depreciation (2,608) (2,344) (5,026)
Amortisation (3,363) (2,865) (5,743)
Share-based payments charge (30) (25) (61)
Non underlying items (1,588) 3,414 4,233
-------------------------------------------- ----------------- ----------------- ------------------
Operating profit 10,742 15,030 30,459
Financial expenses (3,729) (3,834) (7,924)
-------------------------------------------- ----------------- ----------------- ------------------
Profit before tax 7,013 11,196 22,535
-------------------------------------------- ----------------- ----------------- ------------------
Taxation (1,638) (2,477) 336
-------------------------------------------- ----------------- ----------------- ------------------
Profit after tax 5,375 8,719 22,871
-------------------------------------------- ----------------- ----------------- ------------------
All operations of the Group are carried out in the UK, the Company's country of domicile. All revenues therefore arise within the UK and all non-current assets are likewise located in the UK. No single external customer amounts to 10% or more of the Group's revenues.
No asset and liability information is presented as this information is not allocated to operating segments in the regular reporting to the group's Chief Operating Decision Maker and are not measures used by the CODM to assess performance and to make resource allocation decisions.
3. Non-underlying items
Non underlying items are those items of financial performance which, in the opinion of the Directors, should be disclosed separately in order to improve the readers understanding of the trading performance of the Group. Non underlying items comprise the following:
Six months Six months Year
ended ended ended
31 March 2017 31 March 2016 30 September
2016
unaudited unaudited audited
Note GBP000 GBP000 GBP000
------------------------------------------------------------- -------- -------------- -------------- -------------
Acquisition expenses (i) - 1,505 (390)
Integration, reorganisation and redundancy costs (ii) 1,588 704 1,780
Profit arising from the ground rent transaction under IAS17 - (5,623) (5,623)
Amortisation of intangible assets 3,363 2,865 5,743
----------------------------------------------------------------------- -------------- -------------- -------------
Included in administrative expenses 4,951 (549) 1,510
----------------------------------------------------------------------- -------------- -------------- -------------
Fair value movements relating to derivative financial
instruments (iii) (571) 488 1,258
Charges relating to derivative financial instruments (iii) 414 322 646
IAS 17 lease imputed interest 112 21 133
Other financing costs relating to ground rent transactions 1,173 - -
----------------------------------------------------------------------- -------------- -------------- -------------
Included in financial expenses 1,128 831 2,037
----------------------------------------------------------------------- -------------- -------------- -------------
Tax effect:
Current tax (iv) (322) (211) (84)
Deferred tax (v) (587) 393 (2,287)
------------------------------------------------------------- -------- -------------- -------------- -------------
Included in taxation (909) 182 (2,371)
----------------------------------------------------------------------- -------------- -------------- -------------
Total non underlying items 5,170 464 1,176
----------------------------------------------------------------------- -------------- -------------- -------------
(i) In accordance with IFRS 3 (as revised) items associated with business combinations have been taken to the income statement as incurred.
(ii) The Group incurred a number of costs relating to the integration of recent acquisitions and reorganisation of the internal operating and management structure.
(iii) Non underlying items relating to derivative financial instruments include the movements during the year in
the fair value of the Group's interest rate swaps which are not designated as hedging instruments and therefore do not qualify for hedge accounting, together with the quarterly cash settlements and accrual thereof.
(iv) Represents the current tax on items (ii) and (iii) above.
(v) Deferred tax arises in respect of the following:
Six months ended Six months ended Year
Ended
31 March 2017 31 March 2016 30 September 2016
Unaudited unaudited audited
GBP000 GBP000 GBP000
-------------------------------------------------- ----------------- ----------------- ------------------
Derivative financial instruments (note iv) (114) 98 190
Roll over relief arising from property disposals - (1,124) 1,184
Other adjustments 701 633 913
--------------------------------------------------- ----------------- ----------------- ------------------
Total 587 (393) 2,287
--------------------------------------------------- ----------------- ----------------- ------------------
4. Financial expenses
Six months Six months ended Year
ended ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
---------------------------------------------- -------------- ----------------- ------------------
On bank loans and overdrafts 2,438 2,876 5,560
Finance charges in respect of finance leases 163 127 327
---------------------------------------------- -------------- ----------------- ------------------
Financial expenses before adjustments 2,601 3,003 5,887
Amounts relating to derivative financial
instruments (note 3) 1,016 810 1,904
IAS 17 leases imputed interest (note 3) 112 21 133
Total financial expenses 3,729 3,834 7,924
---------------------------------------------- -------------- ----------------- ------------------
5. Taxation
Six months Six months ended Year
ended ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
--------------------------------------------------------------- -------------- ----------------- ------------------
Current tax expense
Current period 2,553 2,300 (4,471)
Non underlying items (note 3) (322) (211) 84
Corporation tax overprovided in previous periods - - 2,281
Total current tax 2,231 2,089 (2,106)
--------------------------------------------------------------- -------------- ----------------- ------------------
Deferred tax expense
Current period (6) (5) (1,027)
Prior year - - 1,182
Deferred tax on non-underlying items (note 3) (587) 393 2,287
Total deferred tax (593) 388 2,442
--------------------------------------------------------------- -------------- ----------------- ------------------
Total tax in the consolidated statement of comprehensive
income 1,638 2,477 336
--------------------------------------------------------------- -------------- ----------------- ------------------
Effective tax rate on profit before tax
(before non underlying items) 20% 20% 8%
--------------------------------------------------------------- -------------- ----------------- ------------------
.
6. Earnings per share
Six months ended Six months ended Year ended
31 March 2017 31 March 2016 30 September 2016
unaudited unaudited audited
GBP000 GBP000 GBP000
------------------------------------------------------------ ----------------- ----------------- ------------------
Profit attributable to ordinary shareholders 5,375 8,719 22,871
Non-underlying items (note 3) 5,170 464 1,176
Profit attributable to ordinary shareholders before
underlying items 10,545 9,183 24,047
Weighted number of shares in issue for basic earnings per
share 64,400,048 62,261,789 63,229,346
Effects of share options in issue 6,562 - -
------------------------------------------------------------ ----------------- ----------------- ------------------
Weighted number of shares in issue for diluted earnings per
share 64,406,610 62,261,789 63,229,346
------------------------------------------------------------ ----------------- ----------------- ------------------
Diluted earnings per share is the basic earnings per share adjusted for the dilutive effect of the conversion into fully paid shares of the weighted average number of share options outstanding during the period.
Earnings per share (pence per share) Basic 8.35p 14.00p 36.17p Diluted 8.35p 14.00p 36.17p Earnings per share before non-underlying items (pence per share) Basic 16.37p 14.75p 38.03p Diluted 16.37p 14.75p 38.03p ------------------------------------------------------------------ ------- ------- -------
Directors and Advisers
Company Number Solicitors
04457287 Charles Russell Speechlys
6 New Street Square
Registered Office London EC4A 3LX
5(th) Floor, Metropolitan House
3 Darkes Lane Pinsent Masons
Potters Bar City Point
Herts EN6 1AG One Rope Maker Street
London EC2Y 9AH
Directors
Farouq Sheikh (Executive Chairman) Bankers
Haroon Sheikh (Chief Executive Officer) The Royal Bank of Scotland PLC
Michael Hill (Group Finance Director) 280 Bishopsgate Karl Monaghan (Non-Executive Director) London EC2M 4RB Mike Adams (Non-Executive Director) Jamie Cumming (Non-Executive Director) Lloyds TSB Bank PLC
Large Corporate 25 Gresham Street
Company Secretary London EC2V 7HN
Michael Hill
Alliance & Leicester PLC
Nominated Adviser and Joint Broker Santander Corporate Banking Panmure Gordon (UK) Limited 2 Triton Square One New Change Regents Place London EC4M 9AF London NW1 3AN
Joint Brokers AIB Group (UK) PLC
WH Ireland Corporate Banking
24 Martin Lane 9/10 Angle Court
London EC4R 0DR London EC2R 7AB
Auditor Registrars
Grant Thornton UK LLP Capita Asset Services
202 Silbury Boulevard Northern House
Milton Keynes Woodsome Park
MK9 1LW Fenay Bridge
Huddersfield
West Yorkshire HD8 0GA
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR OKFDKCBKDNAD
(END) Dow Jones Newswires
June 19, 2017 02:00 ET (06:00 GMT)
1 Year Caretech Chart |
1 Month Caretech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
